Tel: 0333 577 5210
Email: [email protected]
Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies.
Product portfolios focus on multiplex diagnostics for sexually transmitted infections (STIs), antibiotic resistance markers and respiratory conditions. Resistance Guided Therapy improves patient outcomes by empowering practitioners to make informed clinical decisions.